---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-041264"
form_type: "8-K"
ticker: null
cik: "0001397702"
company_name: "Silk Road Medical Inc"
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:13:34.490909+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific closes acquisition of Silk Road Medical for $27.50 per share

## Summary
- Merger closed on September 17, 2024; shareholders received $27.50 per share in cash.
- Silk Road became a wholly owned subsidiary of Boston Scientific; stock delisted from Nasdaq.
- Previous board and officers (including CEO Charles McKhann) replaced by Boston Scientific appointees.
- Existing loan agreement with Oxford Finance repaid in full with 1% prepayment fee; success fee paid to Stifel Bank.
- Company will file Form 15 to terminate SEC reporting obligations.

## SEC filing metadata
- accession: 0001140361-24-041264
- form_type: 8-K
- cik: 0001397702
- company_name: Silk Road Medical Inc
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.03, 2.04, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1397702/000114036124041264/0001140361-24-041264-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1397702/000114036124041264/ef20035938_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-041264
- JSON: https://secwatch.observer/filing/0001140361-24-041264.json
- Plain text: https://secwatch.observer/filing/0001140361-24-041264.txt

## Key facts
- M&A Transactions
  Silk Road Medical Inc underwent a change of control involving Boston Scientific Corporation for $27.50 in cash (closed 2024-09-17).
  - Action: change of control
  - Counterparty: Boston Scientific Corporation
  - Consideration: $27.50 in cash
  - Closing: 2024-09-17
  source text: prior to the Effective Time (subject to certain customary exceptions specified in the Merger Agreement) was cancelled and converted automatically into the right to receive $27.50 in cash, without interest (the “Merger Consideration”) and subject to applicable taxes. Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised
  evidence_url: https://www.sec.gov/Archives/edgar/data/1397702/000114036124041264/0001140361-24-041264-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.